Literature DB >> 23856749

Targeted therapies: the maths behind combination therapy.

Rebecca Kirk.   

Abstract

Year:  2013        PMID： 23856749     DOI： 10.1038/nrclinonc.2013.131

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Gastrointestinal cancer: a step closer to combating acquired resistance in CRC.

Authors:  Lisa Hutchinson
Journal:  Nat Rev Clin Oncol       Date:  2012-06-26       Impact factor: 66.675

2.  Evolutionary dynamics of cancer in response to targeted combination therapy.

Authors:  Ivana Bozic; Johannes G Reiter; Benjamin Allen; Tibor Antal; Krishnendu Chatterjee; Preya Shah; Yo Sup Moon; Amin Yaqubie; Nicole Kelly; Dung T Le; Evan J Lipson; Paul B Chapman; Luis A Diaz; Bert Vogelstein; Martin A Nowak
Journal:  Elife       Date:  2013-06-25       Impact factor: 8.140
  2 in total
  3 in total

Review 1.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

Review 2.  Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma.

Authors:  Francesco Spagnolo; Paola Ghiorzo; Paola Queirolo
Journal:  Oncotarget       Date:  2014-11-15

3.  Caspase mediated synergistic effect of Boswellia serrata extract in combination with doxorubicin against human hepatocellular carcinoma.

Authors:  Mohammad Ahmed Khan; Mhaveer Singh; Masood Shah Khan; Abul Kalam Najmi; Sayeed Ahmad
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.